01 May 2004
The use of marginal-suboptimal donor organs: a practical solution for organs shortage.
George M AbounaAnn Transplant 2004; 9(1): 62-66 :: ID: 142791
Abstract
The demand for organ transplantation has been rapidly increasing as a resultof rising incidence of end-stage organ failure while the supply of cadaver organs from "ideal" or optimaldonors has remained low and inadequate to meet the increasing demand. Yet many so called "marginal" or"suboptimal" organs have been discarded by many centers when many patients die each day while on thewaiting list. In this review important data from our experience and that of several other centers haveconfirmed that using such marginal organs can provide a viable solution to organ shortage. Such organsinclude those from donors > 55 years, children < 5 years, diabetics, non-heart beating cadavers, andorgans with extended preservation. Such organs can be successfully used with appropriate surgical techniquesand immunosuppression protocols and the supply of donor organs can be increased by 25% to 30%.
Keywords: Kidney Transplantation - economics, Renal Artery - abnormalities
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






